AZN logo

AstraZeneca (AZN) Selling, general & administrative expenses

annual SGA:

$20.53B+$2.31B(+12.68%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AZN annual SGA is $20.53 billion, with the most recent change of +$2.31 billion (+12.68%) on December 31, 2024.
  • During the last 3 years, AZN annual SGA has risen by +$4.94 billion (+31.70%).
  • AZN annual SGA is now at all-time high.

Performance

AZN SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

quarterly SGA:

$4.63B-$926.00M(-16.68%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AZN quarterly SGA is $4.63 billion, with the most recent change of -$926.00 million (-16.68%) on March 31, 2025.
  • Over the past year, AZN quarterly SGA has dropped by -$3.00 million (-0.06%).
  • AZN quarterly SGA is now -16.68% below its all-time high of $5.55 billion, reached on December 31, 2024.

Performance

AZN quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

TTM SGA:

$8.35B(NaN%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AZN TTM SGA is $8.35 billion
  • Over the past year, AZN TTM SGA has dropped by -$11.84 billion (-58.65%).
  • AZN TTM SGA is now -88.49% below its all-time high of $72.56 billion.

Performance

AZN TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

AZN Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.7%-0.1%-58.6%
3 y3 years+31.7%-6.8%-52.4%
5 y5 years+71.3%+64.9%-31.6%

AZN Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+31.7%-16.7%+21.6%at high+227.9%
5 y5-yearat high+72.6%-16.7%+68.9%-50.7%+227.9%
alltimeall timeat high>+9999.0%-16.7%+2146.1%-88.5%+227.9%

AZN Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$4.63B(-16.7%)
$20.53B(-0.0%)
Dec 2024
$20.53B(+12.7%)
$5.55B(+5.0%)
$20.53B(+0.2%)
Sep 2024
-
$5.29B(+4.5%)
$20.50B(+1.8%)
Jun 2024
-
$5.06B(+9.3%)
$20.14B(-0.3%)
Mar 2024
-
$4.63B(-16.1%)
$20.19B(+2.2%)
Dec 2023
$18.22B(+1.3%)
$5.52B(+11.9%)
$19.75B(+9.5%)
Sep 2023
-
$4.93B(-3.7%)
$18.05B(+3.0%)
Jun 2023
-
$5.12B(+22.0%)
$17.52B(+1.8%)
Mar 2023
-
$4.19B(+10.2%)
$17.21B(-4.3%)
Dec 2022
$17.98B(+15.4%)
$3.81B(-13.6%)
$17.98B(-7.0%)
Sep 2022
-
$4.40B(-8.5%)
$19.33B(+1.0%)
Jun 2022
-
$4.81B(-3.1%)
$19.14B(+9.2%)
Mar 2022
-
$4.96B(-3.6%)
$17.53B(+12.4%)
Dec 2021
$15.59B(+31.1%)
$5.15B(+22.4%)
$15.59B(+11.7%)
Sep 2021
-
$4.21B(+31.5%)
$13.96B(+11.0%)
Jun 2021
-
$3.20B(+5.7%)
$12.58B(+3.8%)
Mar 2021
-
$3.03B(-14.0%)
$12.12B(+1.9%)
Dec 2020
$11.90B(-0.7%)
$3.52B(+24.5%)
$11.90B(+3.8%)
Sep 2020
-
$2.83B(+3.3%)
$11.46B(-3.8%)
Jun 2020
-
$2.74B(-2.4%)
$11.91B(-2.3%)
Mar 2020
-
$2.81B(-9.0%)
$12.20B(+1.8%)
Dec 2019
$11.98B(+9.1%)
$3.08B(-6.2%)
$11.98B(-2.8%)
Sep 2019
-
$3.29B(+8.7%)
$12.33B(+7.1%)
Jun 2019
-
$3.02B(+16.7%)
$11.51B(+3.5%)
Mar 2019
-
$2.59B(-24.3%)
$11.12B(+0.5%)
Dec 2018
$10.98B(+4.2%)
$3.42B(+38.6%)
$11.07B(+9.0%)
Sep 2018
-
$2.47B(-6.3%)
$10.15B(-1.0%)
Jun 2018
-
$2.63B(+3.8%)
$10.25B(+2.0%)
Mar 2018
-
$2.54B(+1.3%)
$10.05B(+1.6%)
Dec 2017
$10.54B(+8.3%)
$2.50B(-2.6%)
$9.88B(+30.3%)
Sep 2017
-
$2.57B(+5.9%)
$7.59B(+1.3%)
Jun 2017
-
$2.43B(+2.2%)
$7.49B(-8.7%)
Mar 2017
-
$2.38B(+1053.9%)
$8.21B(-3.2%)
Dec 2016
$9.74B(-15.4%)
$206.00M(-91.7%)
$8.48B(-23.7%)
Sep 2016
-
$2.48B(-21.1%)
$11.10B(-2.5%)
Jun 2016
-
$3.14B(+18.7%)
$11.38B(+0.8%)
Mar 2016
-
$2.65B(-6.5%)
$11.29B(-2.0%)
Dec 2015
$11.52B(-13.6%)
$2.83B(+2.7%)
$11.52B(-6.6%)
Sep 2015
-
$2.76B(-9.6%)
$12.33B(-3.6%)
Jun 2015
-
$3.05B(+6.1%)
$12.79B(-0.7%)
Mar 2015
-
$2.88B(-21.1%)
$12.87B(+0.6%)
Dec 2014
$13.32B(+6.5%)
$3.64B(+13.2%)
$12.79B(-7.7%)
Sep 2014
-
$3.22B(+2.7%)
$13.87B(+4.8%)
Jun 2014
-
$3.13B(+12.0%)
$13.23B(+4.1%)
Mar 2014
-
$2.80B(-40.6%)
$12.71B(+1.6%)
Dec 2013
$12.51B(+23.2%)
$4.71B(+82.4%)
$12.51B(+18.6%)
Sep 2013
-
$2.58B(-1.3%)
$10.55B(+1.3%)
Jun 2013
-
$2.62B(+0.9%)
$10.41B(+1.9%)
Mar 2013
-
$2.60B(-5.6%)
$10.22B(+0.6%)
Dec 2012
$10.16B(-11.7%)
$2.75B(+12.2%)
$10.16B(-4.5%)
Sep 2012
-
$2.45B(+1.0%)
$10.64B(-2.6%)
Jun 2012
-
$2.42B(-4.4%)
$10.93B(-4.6%)
Mar 2012
-
$2.54B(-21.4%)
$11.46B(-0.4%)
Dec 2011
$11.51B(+6.7%)
$3.23B(+17.9%)
$11.51B(+5.7%)
Sep 2011
-
$2.74B(-7.4%)
$10.89B(-3.2%)
Jun 2011
-
$2.96B(+14.2%)
$11.25B(+3.9%)
Mar 2011
-
$2.59B(-0.8%)
$10.83B(+0.4%)
DateAnnualQuarterlyTTM
Dec 2010
$10.78B(-7.3%)
$2.61B(-15.6%)
$10.78B(-8.1%)
Sep 2010
-
$3.09B(+21.9%)
$11.73B(+3.1%)
Jun 2010
-
$2.54B(-0.1%)
$11.37B(-3.1%)
Mar 2010
-
$2.54B(-28.6%)
$11.73B(+0.9%)
Dec 2009
$11.63B(+3.8%)
$3.56B(+30.0%)
$11.63B(+2.2%)
Sep 2009
-
$2.74B(-5.6%)
$11.38B(+2.7%)
Jun 2009
-
$2.90B(+18.8%)
$11.08B(+1.3%)
Mar 2009
-
$2.44B(-26.2%)
$10.94B(-2.4%)
Dec 2008
$11.20B(+5.6%)
$3.31B(+35.8%)
$11.20B(-0.6%)
Sep 2008
-
$2.43B(-11.8%)
$11.27B(-1.2%)
Jun 2008
-
$2.76B(+2.0%)
$11.40B(+3.3%)
Mar 2008
-
$2.71B(-19.7%)
$11.04B(+4.0%)
Dec 2007
$10.61B(+13.8%)
$3.37B(+31.1%)
$10.61B(+6.3%)
Sep 2007
-
$2.57B(+7.2%)
$9.98B(+4.1%)
Jun 2007
-
$2.40B(+5.2%)
$9.59B(+1.1%)
Mar 2007
-
$2.28B(-16.8%)
$9.48B(+1.7%)
Dec 2006
$9.32B(+4.7%)
$2.74B(+25.6%)
$9.32B(+1.3%)
Sep 2006
-
$2.18B(-4.8%)
$9.20B(+1.4%)
Jun 2006
-
$2.29B(+8.3%)
$9.07B(+0.7%)
Mar 2006
-
$2.12B(-19.1%)
$9.01B(+1.2%)
Dec 2005
$8.91B(+5.5%)
$2.61B(+27.1%)
$8.91B(+5.1%)
Sep 2005
-
$2.06B(-7.8%)
$8.47B(+0.5%)
Jun 2005
-
$2.23B(+11.1%)
$8.43B(+0.3%)
Mar 2005
-
$2.01B(-8.1%)
$8.41B(+0.0%)
Dec 2004
$8.45B(+11.8%)
$2.18B(+8.6%)
$8.40B(-4.0%)
Sep 2004
-
$2.01B(-8.8%)
$8.75B(+1.9%)
Jun 2004
-
$2.21B(+10.1%)
$8.59B(+7.0%)
Mar 2004
-
$2.00B(-20.9%)
$8.03B(+6.3%)
Dec 2003
$7.55B(+23.1%)
$2.53B(+36.8%)
$7.56B(+10.5%)
Sep 2003
-
$1.85B(+12.7%)
$6.83B(+7.2%)
Jun 2003
-
$1.64B(+7.5%)
$6.38B(+2.0%)
Mar 2003
-
$1.53B(-15.6%)
$6.25B(+1.9%)
Dec 2002
$6.14B(+10.6%)
$1.81B(+30.0%)
$6.14B(+5.8%)
Sep 2002
-
$1.39B(-8.3%)
$5.80B(+0.7%)
Jun 2002
-
$1.52B(+7.5%)
$5.76B(+2.7%)
Mar 2002
-
$1.41B(-4.2%)
$5.61B(+1.8%)
Dec 2001
$5.55B(+6091.9%)
$1.48B(+9.1%)
$5.51B(+36.5%)
Sep 2001
-
$1.35B(-1.2%)
$4.04B(+3.0%)
Jun 2001
-
$1.37B(+4.0%)
$3.92B(+2.9%)
Mar 2001
-
$1.32B(+6.7%)
$3.81B(-18.1%)
Dec 2000
$89.62M(-98.2%)
-
-
Sep 2000
-
$1.23B(-1.9%)
$4.65B(+0.9%)
Jun 2000
-
$1.26B(+3.4%)
$4.61B(-2.8%)
Mar 2000
-
$1.22B(+28.9%)
$4.74B(+34.5%)
Dec 1999
$4.92B(+24.9%)
$944.00M(-20.9%)
$3.53B(+36.6%)
Sep 1999
-
$1.19B(-14.1%)
$2.58B(+85.9%)
Jun 1999
-
$1.39B(+47.8%)
$1.39B(+47.8%)
Dec 1998
$3.94B(>+9900.0%)
-
-
Jun 1998
-
$939.50M(+36.1%)
$939.50M(+36.1%)
Dec 1997
$36.37M(-3.5%)
-
-
Dec 1996
$37.68M(-18.7%)
-
-
Dec 1995
$46.36M(-17.6%)
-
-
Jun 1995
-
$690.40M
$690.40M
Dec 1994
$56.28M(+8.7%)
-
-
Dec 1993
$51.77M(+6.7%)
-
-
Dec 1992
$48.53M(-3.9%)
-
-
Dec 1991
$50.52M(+4.8%)
-
-
Dec 1990
$48.22M
-
-

FAQ

  • What is AstraZeneca annual SGA?
  • What is the all time high annual SGA for AstraZeneca?
  • What is AstraZeneca annual SGA year-on-year change?
  • What is AstraZeneca quarterly SGA?
  • What is the all time high quarterly SGA for AstraZeneca?
  • What is AstraZeneca quarterly SGA year-on-year change?
  • What is AstraZeneca TTM SGA?
  • What is the all time high TTM SGA for AstraZeneca?
  • What is AstraZeneca TTM SGA year-on-year change?

What is AstraZeneca annual SGA?

The current annual SGA of AZN is $20.53B

What is the all time high annual SGA for AstraZeneca?

AstraZeneca all-time high annual SGA is $20.53B

What is AstraZeneca annual SGA year-on-year change?

Over the past year, AZN annual SGA has changed by +$2.31B (+12.68%)

What is AstraZeneca quarterly SGA?

The current quarterly SGA of AZN is $4.63B

What is the all time high quarterly SGA for AstraZeneca?

AstraZeneca all-time high quarterly SGA is $5.55B

What is AstraZeneca quarterly SGA year-on-year change?

Over the past year, AZN quarterly SGA has changed by -$3.00M (-0.06%)

What is AstraZeneca TTM SGA?

The current TTM SGA of AZN is $8.35B

What is the all time high TTM SGA for AstraZeneca?

AstraZeneca all-time high TTM SGA is $72.56B

What is AstraZeneca TTM SGA year-on-year change?

Over the past year, AZN TTM SGA has changed by -$11.84B (-58.65%)
On this page